Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
CHA2DS2-VASc
Chronic kidney disease
Mortality
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
29
03
2021
accepted:
17
06
2021
pubmed:
8
7
2021
medline:
23
11
2021
entrez:
7
7
2021
Statut:
ppublish
Résumé
Chronic kidney disease (CKD) is a leading cause of morbidity and mortality worldwide. Assessment of cardiovascular (CV) and all-cause mortality in CKD patients is of particular importance. CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes, prior stroke, vascular disease, age 65-74 years, and sex) score was originally formulated to predict the annual thromboembolic risk in patients with nonvalvular atrial fibrillation (AF). The calculation of R2CHADS2 and R2CHA2DS2VASc scores awarded an additional 2 points for CrCl < 60 mL/min and GFR < 60 mL/min/1.73 m
Identifiants
pubmed: 34232486
doi: 10.1007/s11739-021-02799-5
pii: 10.1007/s11739-021-02799-5
pmc: PMC8261034
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1737-1742Informations de copyright
© 2021. Società Italiana di Medicina Interna (SIMI).
Références
Am J Nephrol. 2020;51(8):635-640
pubmed: 32702703
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Circulation. 2013 Jan 15;127(2):224-32
pubmed: 23212720
Nephrology (Carlton). 2018 Oct;23 Suppl 4:116-120
pubmed: 30298662
Sci Rep. 2020 Nov 3;10(1):18942
pubmed: 33144647
Kidney Int. 2018 Jun;93(6):1442-1451
pubmed: 29605094
Medicine (Baltimore). 2021 Jan 15;100(2):e23975
pubmed: 33466138
Am Heart J. 2008 Jul;156(1):57-64
pubmed: 18585497
Eur Heart J. 2006 Dec;27(24):3018-26
pubmed: 16731536
Am J Cardiol. 2017 Jul 1;120(1):83-86
pubmed: 28479166
Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3
pubmed: 23507265
Adv Exp Med Biol. 2019;1165:3-15
pubmed: 31399958
Heart Lung Circ. 2016 Mar;25(3):243-9
pubmed: 26481398
ESC Heart Fail. 2016 Dec;3(4):261-269
pubmed: 27867527
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Clin Interv Aging. 2017 Aug 08;12:1233-1238
pubmed: 28848331
Thromb Haemost. 2010 Jul;104(1):45-8
pubmed: 20458437
Dtsch Med Wochenschr. 2019 Jun;144(11):739-742
pubmed: 31163472
Clin Interv Aging. 2018 Apr 05;13:565-571
pubmed: 29670341
Intern Emerg Med. 2017 Jun;12(4):479-486
pubmed: 28161883
Am J Nephrol. 2021;52(5):404-411
pubmed: 33975308
Clin Appl Thromb Hemost. 2017 Sep;23(6):631-637
pubmed: 26759374
Rev Cardiovasc Med. 2019 Dec 30;20(4):209-220
pubmed: 31912712
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Neurology. 2013 Mar 12;80(11):1009-17
pubmed: 23408865
J Thromb Haemost. 2017 Jun;15(6):1065-1077
pubmed: 28375552
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Postepy Kardiol Interwencyjnej. 2018;14(4):391-398
pubmed: 30603029
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180
pubmed: 31119266
Eur Heart J. 2010 Oct;31(19):2369-429
pubmed: 20802247
Europace. 2021 Jun 7;23(6):937-947
pubmed: 33564822
Circulation. 2016 Jan 19;133(3):265-72
pubmed: 26680239
Intern Med J. 2010 Dec;40(12):833-41
pubmed: 21199222
Pol Arch Med Wewn. 2015;125(7-8):545-52
pubmed: 26176231
Medicine (Baltimore). 2017 Oct;96(43):e8338
pubmed: 29069008
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607